BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 72 filers reported holding BEAM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,168,515 | -34.9% | 136,137 | -16.9% | 0.13% | -35.2% |
Q4 2022 | $6,405,827 | +21.8% | 163,790 | +48.3% | 0.20% | +14.0% |
Q3 2022 | $5,261,000 | +67.9% | 110,435 | +36.5% | 0.17% | +60.7% |
Q2 2022 | $3,133,000 | -49.5% | 80,928 | -25.2% | 0.11% | -30.5% |
Q1 2022 | $6,201,000 | -6.7% | 108,227 | +29.8% | 0.15% | +12.4% |
Q4 2021 | $6,646,000 | -15.9% | 83,392 | -8.2% | 0.14% | -8.7% |
Q3 2021 | $7,904,000 | -40.1% | 90,840 | -11.4% | 0.15% | -39.0% |
Q2 2021 | $13,196,000 | +70.7% | 102,523 | +6.1% | 0.25% | +50.0% |
Q1 2021 | $7,731,000 | -17.0% | 96,591 | -15.3% | 0.16% | -21.5% |
Q4 2020 | $9,312,000 | +296.9% | 114,058 | +19.7% | 0.21% | +161.2% |
Q3 2020 | $2,346,000 | -13.3% | 95,285 | -1.4% | 0.08% | -18.4% |
Q2 2020 | $2,705,000 | +52.9% | 96,598 | -1.7% | 0.10% | +3.2% |
Q1 2020 | $1,769,000 | – | 98,276 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,346,934 | $56,443,763 | 54.70% |
HSG Holding Ltd | 796,089 | $19,145,940 | 2.05% |
Redmile Group, LLC | 1,469,725 | $35,346,886 | 1.68% |
ARK Investment Management | 8,783,891 | $211,252,590 | 1.62% |
Casdin Capital, LLC | 570,000 | $13,708,500 | 1.52% |
Deep Track Capital, LP | 1,015,641 | $24,426,166 | 0.94% |
Yiheng Capital Management, L.P. | 560,500 | $13,480,025 | 0.69% |
Temasek Holdings (Private) Ltd | 4,317,789 | $103,842,825 | 0.62% |
FARALLON CAPITAL MANAGEMENT LLC | 4,481,839 | $107,788,228 | 0.54% |
Alphabet Inc. | 321,604 | $7,734,576 | 0.50% |